Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome
Public ClinicalTrials.gov record NCT05322096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RGH-706 is a novel, potent, and orally active MCHR1 antagonist drug candidate discovered and being developed by Gedeon Richter Plc. for weight management. This will be the first Phase 2, proof-of-concept study using RGH-706 and is the third study in the clinical development program for RGH-706. The aim of this study is to evaluate the efficacy, safety, and tolerability of RGH-706 in patients with Prader-Willi Syndrome (PWS).
Study identification
- NCT ID
- NCT05322096
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 39 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 17 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 21, 2022
- Primary completion
- Apr 9, 2024
- Completion
- Apr 9, 2024
- Last update posted
- Jun 2, 2024
2022 – 2024
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rady Children's Hospital-San Diego | San Diego | California | 92123 | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | — |
| Maimonides Medical Center | Brooklyn | New York | 11219 | — |
| NYU Langone Hospital-Long Island | Mineola | New York | 11501 | — |
| Morgan Stanley Children's Hospital of NewYork-Presbyterian | New York | New York | 10032 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
Recently updated Prader-Willi Syndrome trials
Other public records listing Prader-Willi Syndrome. Sorted by last update posted; newest first. Not a recommendation.
- NCT03655223: Early Check: Expanded Screening in Newborns Active, not recruiting
- NCT07607730: Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation Recruiting
- NCT07348601: A Study of CSTI-500 in Patients With Prader-Willi Syndrome Recruiting
- NCT05939453: Impact of Bright Light Therapy on Prader-Willi Syndrome Recruiting
- NCT06144645: A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS Active, not recruiting
- NCT06366464: A Study of Pitolisant in Patients With Prader-Willi Syndrome Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05322096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2024 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05322096 live on ClinicalTrials.gov.